Teleflex Incorporated (TFX) Stock Analysis
Range Bound setup
Healthcare · Medical Instruments & Supplies
Hold if already holding. Not a fresh buy at $130.48, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Negative momentum.
Teleflex provides single-use medical devices for critical care (vascular, interventional) and surgical applications globally across Americas, EMEA, and Asia segments. The company agreed to divest Acute Care, Interventional Urology, and OEM businesses for $2.0B; Jason Weidman was... Read more
Hold if already holding. Not a fresh buy at $130.48, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Negative momentum. Chart setup: RSI 46 mid-range, Bollinger mid-band. Mixed signals. Hold existing position. Score 5.8/10, moderate confidence.
Passes 6/8 gates (clean insider activity, no SEC red flags, news boost analyst 0.70, earnings proximity 46d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: moderate.
Recent developments
updated 2026-06-14Recent Developments — Teleflex Incorporated
Latest news
- NEWS TFX Stock Down Post Q1 Earnings & Revenue Beat, Margins Crash - TradingView — TradingView positive
- NEWS TFX Stock Down Post Q1 Earnings & Revenue Beat, Margins Crash - Yahoo Finance — Yahoo Finance positive
- NEWS Teleflex stock (US8793691069): Interim CEO's routine tax withholding on RSUs - AD HOC NEWS — AD HOC NEWS neutral
- NEWS First Eagle Investment Management LLC Buys 52,300 Shares of Teleflex Incorporated $TFX - MarketBeat — MarketBeat neutral
- NEWS Strs Ohio Acquires 11,002 Shares of Teleflex Incorporated $TFX - MarketBeat — MarketBeat neutral
Generated 2026-06-15T18:11:47Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers·1 ceiling hit
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $130.48, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Negative momentum. Chart setup: RSI 46 mid-range, Bollinger mid-band. Mixed signals. Hold existing position. Target $133.86 (+2.6%), stop $122.94 (−6.1%), A.R:R -0.5:1. Score 5.8/10, moderate confidence.
Take-profit target: $133.86 (+2.6% upside). Target $133.86 (+2.6%), stop $122.94 (−6.1%), A.R:R -0.5:1. Stop-loss: $122.94.
Analyst target reached - limited upside remaining; Negative momentum.
Teleflex Incorporated trades at a P/E of 1864.0 (forward 12.4). TrendMatrix value score: 6.5/10. Verdict: Hold.
17 analysts cover TFX with a consensus score of 3.4/5. Average price target: $146.
What does Teleflex Incorporated do?Teleflex provides single-use medical devices for critical care (vascular, interventional) and surgical applications...
Teleflex provides single-use medical devices for critical care (vascular, interventional) and surgical applications globally across Americas, EMEA, and Asia segments. The company agreed to divest Acute Care, Interventional Urology, and OEM businesses for $2.0B; Jason Weidman was named permanent CEO effective June 8, 2026 following the January 2026 departure of CEO Liam Kelly.